Cite
High expression of INHBA is an adverse prognostic factor for de novo acute myeloid leukemia.
MLA
Si, Ting, et al. “High Expression of INHBA Is an Adverse Prognostic Factor for de Novo Acute Myeloid Leukemia.” Leukemia & Lymphoma, vol. 59, no. 1, Jan. 2018, pp. 114–20. EBSCOhost, https://doi.org/10.1080/10428194.2017.1324157.
APA
Si, T., Lu, Y., Li, F., Jiang, L., Pei, R., & Zhou, J. X. (2018). High expression of INHBA is an adverse prognostic factor for de novo acute myeloid leukemia. Leukemia & Lymphoma, 59(1), 114–120. https://doi.org/10.1080/10428194.2017.1324157
Chicago
Si, Ting, Ying Lu, Fenglin Li, Lei Jiang, Renzhi Pei, and Jeff X. Zhou. 2018. “High Expression of INHBA Is an Adverse Prognostic Factor for de Novo Acute Myeloid Leukemia.” Leukemia & Lymphoma 59 (1): 114–20. doi:10.1080/10428194.2017.1324157.